Skip navigation
We’re currently experiencing an issue affecting a number of our online services, including Online Applications and your 'My account'. This is due to a wider problem with Microsoft Services and they are actively investigating and working to resolve the issue as quickly as possible. Please try again later and we’re sorry for any inconvenience this may cause.

Canlyniadau chwilio

Yn dangos 2326 i 2340 o 3310 canlyniadau

Fitness to practise annual report 2004

This report provides information about the HPC’s work in considering allegations about the Fitness to Practise of registrants.

Did you know our standards are online?

You can easily access our standards from anywhere in a new responsive and print-friendly online format

Reclassification of Gabapentin and Pregabalin

From midnight on 1st April 2019, gabapentin and pregabalin will be reclassified as Schedule 3 controlled drugs, under the Misuse of Drugs Regulations (2001), and Class C of the Misuse of Drugs Act (1971)

We have launched our new whistleblowing policy

Our new whistleblowing policy provides guidance on what to do if you have a concern about wrongdoing in the public interest.

Top